Index
Module 1 • Professional Practice
Evolution & Validation of Practice Standards
38%
Data Tables
Evolution & Validation of Practice Standards
Eric W. Mueller ~2 min read Module 1 of 20
17
/ 45

Evolution and Validation of Practice Standards, Training, and Professional Development

F.

Other Standards

1

The Joint Commission

Medication management chapter

High-alert, hazardous medication standards

ii.

Look-alike/sound-alike medications

iii.

Monitoring of medication response

iv.

Adverse drug event detection, evaluation, and reporting

Duplicate therapy

National Patient Safety Goals

Two-factor patient identification

ii.

Medication reconciliation

iii.

Safe medication use and labeling

iv.

Anticoagulation management and education

Antimicrobial stewardship program

2Centers for Medicare & Medicaid Services (CMS) conditions of participation (42 CFR 482)

Quality assurance and performance improvement programs (Β§482.21)

Medical errors

ii.

Adverse events

Preparation and administration of medications (Β§482.23)

Medical records requirements (Β§482.24)

d.Pharmaceutical services (Β§482.25)

Policies and procedures to minimize drug errors

ii.

Adverse drug reaction and medication error detection and reporting

iii.

Drug information standards

VI.TRAINING OF CRITICAL CARE PHARMACISTS
A.Positions and Policy
1

ACCP position

ACCP clarified its position concerning qualifications of clinical pharmacists providing direct

patient care in a 2013 Board of Regents commentary (Pharmacotherapy 2013;33:888-91): Clinical

pharmacists providing direct patient care β€œshould possess the education, training, and experience

necessary to function effectively, efficiently, and responsibly in this role. Therefore, ACCP believes

that clinical pharmacists engaged in direct patient care should be board certified (or board eligible

if a Board of Pharmacy Specialties [BPS] certification does not exist in their area of practice) and

have established a valid collaborative drug therapy management (CDTM) agreement or have been

formally granted clinical privileges by the medical staff or credentialing system within the health

care environment in which they practice.”

Board certification

ACCP considers BPS certification the cornerstone of eligibility for direct patient care.

ii.

Eligibility

(a)Graduate of an accredited school of pharmacy
(b)Pharmacy licensure
(c)Postgraduate residency training in area of specialization (i.e., PGY2 pharmacy residency),

or PGY1 pharmacy residency and at least 2 years of experience in specialty area with

at least 50% of time in the BPS scope of specialty area, or at least 3–4 years of relevant

experience with at least 50% of time practicing in the specialty area

Ψ΄Ψ±Ψ­ Ψ§Ω„ΩΩŠΨ―ΩŠΩˆ Ψ§Ω„ΨͺΨΉΩ„ΩŠΩ…ΩŠ β€” Ω…Ψ²Ψ§Ω…Ω†Ψ© Ω…ΨΉ Ψ§Ω„Ω€ PDF
Ψ¨Ψ―Ψ‘ Ψ§Ω„ΨͺΨ΄ΨΊΩŠΩ„ Ω…Ω†: Ψ§Ω„Ψ―Ω‚ΩŠΩ‚Ψ© 16 فΨͺΨ­ ΨΉΩ„Ω‰ YouTube